Zendico Consultants Ltd – Trademark Portfolio
Entity Type: 99
Zendico Consultants Ltd holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ISABEL FAY. The owner is based in Limassol.
21 Vasili Michailidi
Limassol 3026 , CY
Showing of trademarks Trademarks
Trademark Classifications
Zendico Consultants Ltd's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Zendico Consultants Ltd have?
Zendico Consultants Ltd has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.
What trademark classes does Zendico Consultants Ltd file in?
Zendico Consultants Ltd files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Zendico Consultants Ltd's most well-known trademarks?
Zendico Consultants Ltd's registered trademark portfolio includes well-known marks such as ISABEL FAY. These are among 1 currently registered trademark in the portfolio.
What is Zendico Consultants Ltd's trademark registration success rate?
Zendico Consultants Ltd has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.